Sugi Predict

Sugi Predict / Compounds / SCHEMBL5614136

SCHEMBL5614136

SCHEMBL5614136

Oc1cc(F)ccc1Oc1ccccc1-c1nnn[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA3 P07451 1/20 0.34
▸ CA6 P23280 1/20 0.34
▸ CA5A P35218 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ CA14 Q9ULX7 1/20 0.34
▸ CA5B Q9Y2D0 1/20 0.34
▸ KMT2A Q03164 5/20 0.34
▸ MEN1 O00255 4/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ CASP6 P55212 2/20 0.34
▸ GAA P10253 1/20 0.33
▸ LPAR2 Q9HBW0 1/20 0.33
▸ MAPT P10636 3/20 0.33
▸ ALOX15 P16050 3/20 0.33
▸ LMNA P02545 2/20 0.33
▸ ALOX12 P18054 2/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ IDO1 P14902 2/20 0.33
▸ TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5613841 0.86 TTR (0.41) MAPTLMNAIDO1
SCHEMBL5613919 0.86 IDO1 (0.36) KMT2AMEN1GAAMAPTALOX15
SCHEMBL5614004 0.86 TTR (0.47) KMT2AMEN1NPC1MAPTLMNA
SCHEMBL5607912 0.86 KMT2A (0.38) KMT2AMEN1NPC1GAAMAPT
SCHEMBL25160138 0.80 AMY1A (0.42) CA3CA6CA5ACA9CA14
SCHEMBL5607474 0.78 CASP6 (0.53) KMT2AMEN1CASP6GAAIDO1
SCHEMBL5628973 0.78 ALOX15 (0.40) KMT2AMEN1GAAMAPTALOX15
SCHEMBL5613904 0.76 TTR (0.50) LPAR2MAPTLMNAIDO1
SCHEMBL25160087 0.75 IDO1 (0.51) CA3CA6CA5ACA9CA14
SCHEMBL1773419 0.71 IDO1 (0.52) KMT2AMEN1NPC1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838300-A2 2-(2 OR 4-SUBSTITUTED ARYLOXY)-PHENOL DERIVATIVES AS ANTIBACTERIAL AGENTS Emergent Product Development Gaithersburg Inc. (US) 2007-10-03 — — EP claimed
US-20060211697-A1 2-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG, INC. 2006-09-21 — — US claimed
WO-2006071471-A2 2-(2 OR 4-SUBSTITUTED ARYLOXY)-PHENOL DERIVATIVES AS ANTIBACTERIAL AGENTS EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. (US) 2006-07-06 — — WO claimed
EP-1838300-A2 2-(2 OR 4-SUBSTITUTED ARYLOXY)-PHENOL DERIVATIVES AS ANTIBACTERIAL AGENTS Emergent Product Development Gaithersburg Inc. (US) 2007-10-03 — — EP disclosed
US-20060211697-A1 2-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG, INC. 2006-09-21 — — US disclosed
WO-2006071471-A2 2-(2 OR 4-SUBSTITUTED ARYLOXY)-PHENOL DERIVATIVES AS ANTIBACTERIAL AGENTS EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. (US) 2006-07-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211697-A1 2-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents TYR, NFE2L2, CYP1A1 CA3 4644/4885CA6 3315/4885CA5A 2658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.